Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $FLGT vs $SBC | Chartloom

Compare

$FLGT vs $SBC

Fulgent Genetics Inc · SBC Medical Group Holdings Inc

FLGT

Fulgent Genetics Inc

SBC

SBC Medical Group Holdings Inc

Compare $FLGT vs $SBC

Comparing Fulgent Genetics Inc and SBC Medical Group Holdings Inc

FLGTFulgent Genetics Inc

SBCSBC Medical Group Holdings Inc

FLGTFulgent Genetics Inc

Market cap

$597M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.62x

Rev growth (TTM)

6.8%

YTD performance

-17.9%

52W performance

-6.6%

FCF yield

-17.4%

SBCSBC Medical Group Holdings Inc

Market cap

$536M

P/E (TTM)

10.94x

Forward P/E (NTM)

11.06x

Forward P/S (NTM)

2.68x

Rev growth (TTM)

-6.9%

YTD performance

20.8%

52W performance

26.0%

FCF yield

11.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FLGT

SBC

Detailed metrics comparison

FLGT

Fulgent Genetics Inc

SBC

SBC Medical Group Holdings Inc

Market Cap

FLGT$597M

SBC$536M

Enterprise Value

FLGT$574M

SBC$390M

Price

FLGT$21.01

SBC$5.23

P/E Ratio

FLGTN/A

SBC10.94x

P/S Ratio

FLGT1.84x

SBC3.06x

EV/Sales

FLGT1.77x

SBC2.23x

EV/EBITDA

FLGT3.11x

SBC5.12x

P/B Ratio

FLGT0.60x

SBC2.11x

P/FCF Ratio

FLGTN/A

SBC8.84x

EV/FCF

FLGT-5.53x

SBC6.43x

PEG Ratio

FLGTN/A

SBC0.24x

Forward P/E (NTM)

FLGTN/A

SBC11.06x

Forward P/S (NTM)

FLGT1.62x

SBC2.68x

Revenue (TTM)

FLGT$324M

SBC$175M

Revenue Growth (YoY)

FLGT6.8%

SBC-6.9%

Forward Rev Growth

FLGT15.4%

SBC10.2%

Gross Margin (TTM)

FLGT35.6%

SBC71.9%

Operating Margin (TTM)

FLGT0.0%

SBC37.3%

EBITDA Margin (TTM)

FLGT-29.1%

SBC39.2%

Net Margin (TTM)

FLGT-26.0%

SBC28.0%

FCF Margin (TTM)

FLGT-32.0%

SBC34.7%

Net Income (TTM)

FLGT$-84M

SBC$49M

FCF (TTM)

FLGT$-104M

SBC$61M

EPS (TTM)

FLGT-$3.01

SBC$0.48

ROE (TTM)

FLGT-787.0%

SBC19.3%

ROA (TTM)

FLGT-722.0%

SBC13.1%

ROIC (TTM)

FLGT-785.0%

SBC16.9%

Cash

FLGT$26M

SBC$184M

Debt

FLGT$4M

SBC$38M

Net Cash/Debt

FLGT$22M

SBC$146M

Current Ratio (TTM)

FLGT6.34x

SBC3.31x

Quick Ratio (TTM)

FLGT4.72x

SBC3.19x

Debt/Equity (TTM)

FLGT0.00x

SBC0.14x

Debt/Assets (TTM)

FLGT0.0%

SBC0.0%

Interest Coverage (TTM)

FLGTN/A

SBCN/A

Net Debt/EBITDA (TTM)

FLGT0.00x

SBC0.00x

Beta

FLGT1.03

SBC0.59

52W Performance

FLGT-6.6%

SBC26.0%

YTD Performance

FLGT-17.9%

SBC20.8%

% from 52W High

FLGT-32.3%

SBC-6.8%

% from 52W Low

FLGT56.1%

SBC88.1%

Asset Turnover (TTM)

FLGT0.28x

SBC0.47x

FCF Yield (TTM)

FLGT-17.4%

SBC11.3%

Earnings Yield (TTM)

FLGT-14.1%

SBC9.1%

Dividend Yield (TTM)

FLGTN/A

SBCN/A

Rule of 40

FLGT-25.2

SBC27.7

EV/GP/RG

FLGT0.03

SBC0.19

Ticker research

View FLGT research View SBC research

Metric	FLGT Fulgent Genetics Inc	SBC SBC Medical Group Holdings Inc
Market & Valuation
Market Cap	$597M	$536M
Enterprise Value	$574M	$390M
Price	$21.01	$5.23
P/E Ratio	N/A	10.94x
P/S Ratio	1.84x	3.06x
EV/Sales	1.77x	2.23x
EV/EBITDA	3.11x	5.12x
P/B Ratio	0.60x	2.11x
P/FCF Ratio	N/A	8.84x
EV/FCF	-5.53x	6.43x
PEG Ratio	N/A	0.24x
Forward P/E (NTM)	N/A	11.06x
Forward P/S (NTM)	1.62x	2.68x
Revenue & Growth
Revenue (TTM)	$324M	$175M
Revenue Growth (YoY)	6.8%	-6.9%
Forward Rev Growth	15.4%	10.2%
Profitability
Gross Margin (TTM)	35.6%	71.9%
Operating Margin (TTM)	0.0%	37.3%
EBITDA Margin (TTM)	-29.1%	39.2%
Net Margin (TTM)	-26.0%	28.0%
FCF Margin (TTM)	-32.0%	34.7%
Net Income (TTM)	$-84M	$49M
FCF (TTM)	$-104M	$61M
EPS (TTM)	-$3.01	$0.48
ROE (TTM)	-787.0%	19.3%
ROA (TTM)	-722.0%	13.1%
ROIC (TTM)	-785.0%	16.9%
Financial Health
Cash	$26M	$184M
Debt	$4M	$38M
Net Cash/Debt	$22M	$146M
Current Ratio (TTM)	6.34x	3.31x
Quick Ratio (TTM)	4.72x	3.19x
Debt/Equity (TTM)	0.00x	0.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.03	0.59
52W Performance	-6.6%	26.0%
YTD Performance	-17.9%	20.8%
% from 52W High	-32.3%	-6.8%
% from 52W Low	56.1%	88.1%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	0.47x
FCF Yield (TTM)	-17.4%	11.3%
Earnings Yield (TTM)	-14.1%	9.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-25.2	27.7
EV/GP/RG	0.03	0.19
Ticker research	View FLGT research	View SBC research

Valuation

P/E Ratio

SBC

10.94x

P/S Ratio

FLGT

1.84x

SBC

3.06x

EV/FCF

FLGT

-5.53x

SBC

6.43x

Growth & revenue

Revenue Growth TTM

FLGT

6.8%

SBC

-6.9%

Forward Revenue Growth

FLGT

15.4%

SBC

10.2%

Profitability & performance

Gross Margin

SBC

71.9%

FLGT

35.6%

ROE

SBC

19.3%

FLGT

-787.0%

FCF Yield %

SBC

11.3%

FLGT

-17.4%

52-Week Performance

SBC

26.0%

FLGT

-6.6%

Detailed metrics comparison

FLGT

Fulgent Genetics Inc

SBC

SBC Medical Group Holdings Inc

Market Cap

FLGT$597M

SBC$536M

Enterprise Value

FLGT$574M

SBC$390M

Price

FLGT$21.01

SBC$5.23

P/E Ratio

FLGTN/A

SBC10.94x

P/S Ratio

FLGT1.84x

SBC3.06x

EV/Sales

FLGT1.77x

SBC2.23x

EV/EBITDA

FLGT3.11x

SBC5.12x

P/B Ratio

FLGT0.60x

SBC2.11x

P/FCF Ratio

FLGTN/A

SBC8.84x

EV/FCF

FLGT-5.53x

SBC6.43x

PEG Ratio

FLGTN/A

SBC0.24x

Forward P/E (NTM)

FLGTN/A

SBC11.06x

Forward P/S (NTM)

FLGT1.62x

SBC2.68x

Revenue (TTM)

FLGT$324M

SBC$175M

Revenue Growth (YoY)

FLGT6.8%

SBC-6.9%

Forward Rev Growth

FLGT15.4%

SBC10.2%

Gross Margin (TTM)

FLGT35.6%

SBC71.9%

Operating Margin (TTM)

FLGT0.0%

SBC37.3%

EBITDA Margin (TTM)

FLGT-29.1%

SBC39.2%

Net Margin (TTM)

FLGT-26.0%

SBC28.0%

FCF Margin (TTM)

FLGT-32.0%

SBC34.7%

Net Income (TTM)

FLGT$-84M

SBC$49M

FCF (TTM)

FLGT$-104M

SBC$61M

EPS (TTM)

FLGT-$3.01

SBC$0.48

ROE (TTM)

FLGT-787.0%

SBC19.3%

ROA (TTM)

FLGT-722.0%

SBC13.1%

ROIC (TTM)

FLGT-785.0%

SBC16.9%

Cash

FLGT$26M

SBC$184M

Debt

FLGT$4M

SBC$38M

Net Cash/Debt

FLGT$22M

SBC$146M

Current Ratio (TTM)

FLGT6.34x

SBC3.31x

Quick Ratio (TTM)

FLGT4.72x

SBC3.19x

Debt/Equity (TTM)

FLGT0.00x

SBC0.14x

Debt/Assets (TTM)

FLGT0.0%

SBC0.0%

Interest Coverage (TTM)

FLGTN/A

SBCN/A

Net Debt/EBITDA (TTM)

FLGT0.00x

SBC0.00x

Beta

FLGT1.03

SBC0.59

52W Performance

FLGT-6.6%

SBC26.0%

YTD Performance

FLGT-17.9%

SBC20.8%

% from 52W High

FLGT-32.3%

SBC-6.8%

% from 52W Low

FLGT56.1%

SBC88.1%

Asset Turnover (TTM)

FLGT0.28x

SBC0.47x

FCF Yield (TTM)

FLGT-17.4%

SBC11.3%

Earnings Yield (TTM)

FLGT-14.1%

SBC9.1%

Dividend Yield (TTM)

FLGTN/A

SBCN/A

Rule of 40

FLGT-25.2

SBC27.7

EV/GP/RG

FLGT0.03

SBC0.19

Ticker research

View FLGT research View SBC research

Metric	FLGT Fulgent Genetics Inc	SBC SBC Medical Group Holdings Inc
Market & Valuation
Market Cap	$597M	$536M
Enterprise Value	$574M	$390M
Price	$21.01	$5.23
P/E Ratio	N/A	10.94x
P/S Ratio	1.84x	3.06x
EV/Sales	1.77x	2.23x
EV/EBITDA	3.11x	5.12x
P/B Ratio	0.60x	2.11x
P/FCF Ratio	N/A	8.84x
EV/FCF	-5.53x	6.43x
PEG Ratio	N/A	0.24x
Forward P/E (NTM)	N/A	11.06x
Forward P/S (NTM)	1.62x	2.68x
Revenue & Growth
Revenue (TTM)	$324M	$175M
Revenue Growth (YoY)	6.8%	-6.9%
Forward Rev Growth	15.4%	10.2%
Profitability
Gross Margin (TTM)	35.6%	71.9%
Operating Margin (TTM)	0.0%	37.3%
EBITDA Margin (TTM)	-29.1%	39.2%
Net Margin (TTM)	-26.0%	28.0%
FCF Margin (TTM)	-32.0%	34.7%
Net Income (TTM)	$-84M	$49M
FCF (TTM)	$-104M	$61M
EPS (TTM)	-$3.01	$0.48
ROE (TTM)	-787.0%	19.3%
ROA (TTM)	-722.0%	13.1%
ROIC (TTM)	-785.0%	16.9%
Financial Health
Cash	$26M	$184M
Debt	$4M	$38M
Net Cash/Debt	$22M	$146M
Current Ratio (TTM)	6.34x	3.31x
Quick Ratio (TTM)	4.72x	3.19x
Debt/Equity (TTM)	0.00x	0.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.03	0.59
52W Performance	-6.6%	26.0%
YTD Performance	-17.9%	20.8%
% from 52W High	-32.3%	-6.8%
% from 52W Low	56.1%	88.1%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	0.47x
FCF Yield (TTM)	-17.4%	11.3%
Earnings Yield (TTM)	-14.1%	9.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-25.2	27.7
EV/GP/RG	0.03	0.19
Ticker research	View FLGT research	View SBC research